Literature DB >> 28432941

Validation of a SPE HPLC-UV method for the quantification of a new ER-specific photosensitizer OR-141 in blood serum using total error concept.

Emilie Bony1, Yohan Mace2, Adán Pinto3, David Delvaux3, Robert Kiss4, Olivier Riant5, Olivier Feron6, Joëlle Quetin-Leclercq7.   

Abstract

The aim of this work is to develop the first validated HPLC-UV method quantification in blood serum for a new endoplasmic reticulum (ER)-specific benzophenazine photosensitizer (OR-141). A fast solid phase extraction (SPE) cleaning sample procedure was achieved on C18 encapped (ec) SPE cartridges and the separation was performed on a RP-18e column (5μM) using an isocratic elution with methanol. The method has been fully validated according to accuracy profiles based on total error and tolerance intervals. Calibration was performed in the matrix and trueness (<4.25% relative bias), repeatability (<4.75% relative standard deviation (RSD)), intermediate precision (<5.37% RSD), selectivity, response function, linearity, and dilution effect were evaluated for both OR-141 regio-isomers. Afterwards the developed method was successfully applied to perform the quantitative determination of OR-141 in mouse blood serum samples in a preliminary pharmacokinetic study.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzophenazines; Method validation; Photodynamic therapy; Total error concept

Mesh:

Substances:

Year:  2017        PMID: 28432941     DOI: 10.1016/j.jpba.2017.03.060

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Preclinical Evaluation of White Led-Activated Non-porphyrinic Photosensitizer OR141 in 3D Tumor Spheroids and Mouse Skin Lesions.

Authors:  Bastien Doix; Estelle Bastien; Alix Rambaud; Adán Pinto; Caroline Louis; Vincent Grégoire; Olivier Riant; Olivier Feron
Journal:  Front Oncol       Date:  2018-09-21       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.